Objective: This descriptive study was conducted to investigate levels compliance to medication and diet therapy of patients with hypertension and individual factors that may affect compliance.


Methods: This study was conducted with the 250 patients who were volunteer and willing to participate in the study diagnosed with hypertension at least six months ago in a Hypertension Clinic of a University Hospital in Istanbul between the dates of November 1 December 31,2011. Data were gathered by survey form,about Bliefs about Medication Compliance Scale(BMCS) and the Beliefs about Diet Compliance Scale(BDCS).
Results: The mean age of the patients was 62.9±1.15.65.2% of the patients were female,82% were married,33.2% were primary school graduates,67% had stress in their daily life,44.4% had regular exercise and 55.2% had hypertension in their family.The mean scores of the medication and diet benefit subscales of the patients who participated in our study(The benefit sub-dimension of the BMCS was 21.44±5.39,the benefit sub-dimension of the BDCS was 23.44±5.50)was found to be higher than the mean score of the sub-dimensions of the obstacle(The obstacle sub-dimension of the BMCS was 17.52±4.66, the obstacle sub-dimension of the BDCS was 12.9±3.59).Generally, the compliance of the patients who participated in our study to the medication treatment was found to be good and their adaptation to the dietary treatment was moderate.In the study,it was determined that patients who had hypertension in their families were compatible with medication and diet therapy,patients who exercised regular exercise were not compatible with medication, but were compatible with diet therapy and patients with stress in daily life were not compatible with medication and diet therapy(p<0.05).
Conclusion: Patientswhoparticipatedinthestudyhadgoodlevels of compliance with medication and diet therapy.In the study,it was determinedthat patients whohadhypertension in their families were compatible with medication and diet therapy,patients who exercised regular exercise were notcompatible with medication,butwerecompatible with diet therapy and patients with stress indailylifewerenotcompatiblewith medicationanddiettherapy.

Objective: The purpose of this descriptive study was to determine the effect of illness perceptions on medication adherence in patients undergoing percutaneous coronary intervention.
Methods: The study population consisted of 476 patients who were admitted to the cardiology department of a training and research hospital between July 1, 2017 and November 30, 2017. The study sample consisted of 192 patients who were selected using power analysis according to the research inclusion criteria. Data were collected using a Personal Information Form, the Illness Perception Scale Disease Perception Scale and the Morisky Medication Adherence Scale. Data were analyzed using descriptive statistics (i.e. mean, standard deviation, frequency and percentage distributions), Student's t test and Paired Samples t test were used in the evaluation of the data. A significance level of p <0.05 was used for the analyzes.
Results: Majority of the patients participating in the study were male, were overweight, were married, were literate/primary school graduates and the average age was 59,7±11,1. It was determined that the majority of the patients knew the names of the drugs they used, they had additional chronic diseases. Most of the patients indicated stress, genetic makeup or diet-eating habits as the causes of their disease. It was determined that the patients had a moderate level of medication adherence, their medication adherence increased as the frequency of their drug usage decreased and their illness perceptions affected their medication adherence (p<0.05). As the patients' level of understanding, controlling and managing the disease increased, the drug compliance increased (p=0,002; p=0,001).
Conclusion: It was determined that the drug compliance of the patients who underwent percutaneous coronary intervention was moderate and the disease perceptions affected the compliance of the drug.

Pulmonary hypertension is a progressive destructive disease characterized by vascular changes. Proliferation and vasoconstriction of pulmonary arteries lead to right heart failure and death. While patients usually have symptoms, such as dyspnea, fatigue, weakness and edema, at the beginning, the syncope and presyncope can be observed in late periods. The mentioned symptoms imitate other cardio-pulmonary diseases and a delay occurs in establishing a diagnosis in patients with pulmonary hypertension. Pulmonary hypertension is a chronic disease, restricts the daily life and the patients face with many symptoms which reduce quality of life. All of the current medical treatments and cares of the patients are complicated and are largely palliative. The aim of treatment and care of the patients is to decrease morbidity and mortality and to heal symptoms and functional situation. Frequent hospitalization occurs in pulmonary hypertension cases. Nurses should know the high risk-bearing patient groups in terms of pulmonary hypertension. Nurses have important roles in training of patients and patient relatives, care of patients, administration of medical treatment, symptom management and patient follow-up in pulmonary hypertension. In this rewiev was discussed in order to present etiology, classification, pathophysiology, treatment and care of pulmonary hypertension.

Recent studies have focused the effect of intestinal microbiota on individuals, since intestinal microbiota has an impact on human health and disease, and is associated with many diseases, including cardiovascular diseases (CVD). CVD are an important group of diseases with a high incidence and can result in death. 31% of the deaths in the world are due to CVD and it is estimated that this value will reach 41% after a decade. Studies have shown that immune system, inflammation process, endothelial damage and vascular changes affect intestinal microbiota and as a result many CVD and metabolic diseases develop. This situation has developed the idea that the diseases can be detected and prevented by examining and regulating intestinal microbiota. The most important role in protecting individuals from diseases and developing and sustaining health belongs to nurses. Nurses should increase their knowledge of current approaches, know the basic structure and functions of microbial communities and be able to reflect their knowledge and skills to their care. In cardiovascular health and disease, supporting and increasing awareness of the impact of intestinal microbiota for with the additional prospective studies will be an important step in the development of health and disease prevention strategies. In the regulation of intestinal microbiota with the studies to be done, it is predicted that, with the use of strategies developed for CVD in individuals with risk, can be protected from CVD and that cardiovascular health can be sustained.

Having chronic disease leads to possible problems in physiological, psychological and social environment. The use of conceptual models in nursing care management provides a holistic care in biopsychosocial approach to patient with chronic disease. According to the Roy Adaptation Model, one of the common used models in nursing, the individual / patient uses a kind of coping mechanisms for respond to kind stimulant and responds with their behavior. Adaptive responses to stimulant improve the integrity of the individual, while incompatible responses adversely affect integrity.
In this case report; the nursing care of a patient diagnosed with essential hypertension and who previously had a compliance problem was carried out in accordance with the adaptation areas of the Roy Adaptation Model.